Pregnancy and Birth

The updated Committee Statement reaffirmed the safety and benefits of influenza, COVID-19, Tdap, and RSV vaccines during pregnancy while addressing misinformation and disparities.

An institution-wide policy allowing elective induction at 39 weeks was linked to lower cesarean delivery and NICU admission rates.

The findings underscore the need for more rigorous and diverse clinical studies evaluating digital interventions.

Speaking at the SMFM 2026 Pregnancy Meeting, Molina emphasized that HIPAA protections, clear policies, and staff training are central to equitable ob-gyn care for immigrant patients.

Preeclampsia was associated with an elevated risk of early kidney damage, highlighting gaps in postpartum surveillance.

In this Q&A interview, Marie Anderson, MD, of Columbia University, highlights a study presented at SMFM 2026 linking abortion restriction and increased rates of maternal death in the United States.

A new analysis finds that most pregnant patients with depression or anxiety discontinue SSRIs/SNRIs—and face nearly double the risk of mental health emergencies.

The Society for Maternal-Fetal Medicine has released updated checklists to guide evidence-based management of monochorionic twin pregnancies and reduce preventable complications.

If allowed by prescribers, patients can complete pregnancy tests outside of a medical setting, but must complete pre-treatment pregnancy tests in a medical setting, according to the FDA.

Addressing geographic inequities in maternal-fetal medicine care through workforce investment and policy reform is critical to improving pregnancy outcomes and reducing maternal deaths, according to SMFM.

A look into what to expect at the 2026 Society for Maternal-Fetal Medicine 2026 Pregnancy Meeting from Las Vegas, Nevada, with Christina Paidas Teefey, MD, a maternal fetal medicine specialist.

In a large preconception cohort, more than 40% of pregnancy planners reported very early home pregnancy testing, which was associated with higher risks of false-negative results and detection of very early pregnancy losses.

Kevin Ault, MD, of the NFID, explains the importance of data- and evidence-based guidance, such as that of ACOG, for maternal immunization recommendations.

ACOG continues to support maternal immunization against COVID-19, flu, and RSV amid growing public questions about vaccine safety during pregnancy.

Take a quick look at everything you may have missed in January, from our latest video interviews to new clinical trial data to a FAQ on cervical cancer.

The scope of the marketplace contrasted sharply with the available evidence.

Winok Lapidaire, PhD, explains how early postpartum physician-guided blood pressure self-management after hypertensive pregnancy was associated with higher white matter volumes.

Universal prenatal syphilis screening legislation in Michigan was followed by substantial increases in early third-trimester testing among Medicaid enrollees.

United States labor induction rates have expanded to 37 and 38 weeks despite a lack of randomized evidence supporting non–medically indicated induction before 39 weeks.

A new AHA scientific statement outlines how earlier prevention, rapid diagnosis and timely treatment can reduce the risks of maternal stroke during pregnancy and postpartum.

The AAP'S 2026 schedule has been endorsed by 12 medical and health organizations, including the American College of Nurse Midwives and the American College of Obstetricians and Gynecologists.

In patients with diet-controlled gestational diabetes, continuing pregnancy beyond 39 weeks was associated with increasing maternal and neonatal risks.

A large cohort study found that prenatal exposure to acid-suppressive medications was not associated with neuropsychiatric disorders in children.

Early postpartum blood pressure self-monitoring with physician-guided medication adjustment was linked to sustained reductions in blood pressure among women with hypertensive pregnancies.

A nationwide Norwegian cohort study suggests that prenatal factors, including fetal growth and maternal diabetes, may influence the risk of developing multiple sclerosis in adulthood.